Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple exercise routine ease diabetic nerve damage?

NCT ID NCT07075367

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a 12-week exercise program that works the trunk, hips, knees, and ankles can reduce symptoms and improve quality of life in people with diabetic peripheral neuropathy. Sixty-four adults with type 2 diabetes and nerve damage will be randomly assigned to either the full-leg program or a standard foot-and-ankle exercise routine. The goal is to see if the more comprehensive approach better eases nerve pain, improves balance, and reduces fear of falling.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
exercise program
What this could lead to
If it works, this could offer a simple, drug-free way to reduce nerve pain and improve balance and quality of life for people with diabetic neuropathy.
What could go wrong
This is a small, early-stage trial with only 64 participants. Exercise may not help everyone, and results may not apply to more active people or those with severe neuropathy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult individuals aged between 45 and 75 years, male or female, diagnosed with DM2; * DPN diagnosis based on vibration sensitivity tests assessed by a 128 Hz tuning fork and tactile sensitivity measured by a 10 g monofilament * Sedentary or irregularly active individuals (level A) according to the Physical Activity Level Classification - IPAQ * Score of at least 5 points on the Functional Independence Measure (FIM), i.e., requires supervision, but without physical contact * Absence of diabetic foot ulcer (DFU) for at least one month * No amputation or at most amputation of fingers, except for the hallux Exclusion Criteria: * Individuals involved in physical training programs simultaneously with the intervention * History of surgical intervention in the lower limbs or spine * Use of walking assistance devices * Diagnosis of severe cardiovascular disorder * Diagnosis of other neurological impairments in addition to DPN * Presence of dementia or inability to provide consistent information * Severe retinopathy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic peripheral neuropathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.